Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study.

Ann Hematol · 2026 · PMC12999601 · PMID 41848910

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

a trend toward significancep = 0.057so close (0.05 < p ≤ 0.1)

In the multivariate model, advanced-stage emerged as an independent predictor (OR 3.02, 95% CI 1.11–8.24, P = 0.031), while B symptoms showed only a trend toward significance (OR 7.01, 95% CI 0.94–52.2, p = 0.057).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.